C. Chapellier

Papers

Total Citations

H-Index

About

Dr. C. Chapellier is a pioneering figure in the application of robotic stereotactic radioablation for breast cancer treatment, with a focused research career spanning the integration of advanced radiotherapy with oncologic surgery. Her seminal 2009 work, "Robotic Stereotactic Radioablation Concomitant With Neo-Adjuvant Chemotherapy for Breast Tumors," established a novel paradigm for combining high-precision radiation with systemic therapy before tumor resection, earning 30 citations and laying the groundwork for non-invasive breast cancer management. Building on this foundation, she led the phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer" (2018), which refined dose escalation strategies to improve local control while minimizing toxicity. Dr. Chapellier’s contributions are particularly notable for their translational impact—her research directly addresses the clinical challenge of reducing surgical morbidity through stereotactic techniques, bridging radiation oncology and surgical oncology. Though her citation counts reflect a specialized niche, her work has influenced protocols for early-stage breast cancer, demonstrating how robotic radiosurgery can safely augment neoadjuvant chemotherapy. Her career exemplifies how targeted, methodical investigation can reshape treatment paradigms in oncologic surgery.